An age-based multiscale mathematical model of the hepatitis C virus life-cycle during infection and therapy: Including translation and replication

The dynamics of hepatitis C virus (HCV) RNA during translation and replication were added to an age-based multiscale mathematical model of HCV infection and treatment. The model allows the study of the production of HCV inside infected cells, which are later released as virus in the plasma, available to infect other cells. This is the first model to our knowledge to consider both positive and negative strands of HCV RNA with an age-based multiscale approach. Simulation of the effectiveness of direct acting antiviral (DAA) drugs in blocking HCV RNA intracellular production and release of new virions, and enhancing their depletion were performed. Changes on the set of parameters allowed the validation of the model comparing it to distinct experiments: in vitro and in vivo under therapy.

[1]  Alan S. Perelson,et al.  Second‐phase hepatitis C virus RNA decline during telaprevir‐based therapy increases with drug effectiveness: Implications for treatment duration , 2011, Hepatology.

[2]  J. Feld,et al.  An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver. , 2012, Canadian journal of gastroenterology & hepatology.

[3]  Daniel Coombs,et al.  An age-structured model of hiv infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells. , 2004, Mathematical biosciences and engineering : MBE.

[4]  Alan S. Perelson,et al.  Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model , 2013, PLoS Comput. Biol..

[5]  J. Ball,et al.  Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA. , 2001, Journal of virological methods.

[6]  Carlos Castillo-Chavez,et al.  How May Infection-Age-Dependent Infectivity Affect the Dynamics of HIV/AIDS? , 1993, SIAM J. Appl. Math..

[7]  Sandip Banerjee,et al.  Modeling the dynamics of hepatitis C virus with combined antiviral drug therapy: interferon and ribavirin. , 2011, Mathematical biosciences.

[8]  Libin Rong,et al.  Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life , 2013, Proceedings of the National Academy of Sciences.

[9]  N. Dixit.  Advances in the Mathematical Modelling of Hepatitis C Virus Dynamics , 2008 .

[10]  R. Sanjuán,et al.  Viral Mutation Rates , 2010, Journal of Virology.

[11]  Carlos Castillo-Chavez,et al.  Diseases with chronic stage in a population with varying size. , 2003, Mathematical biosciences.

[12]  Fred Brauer,et al.  Continuous-Time Age-Structured Models in Population Dynamics and Epidemiology , 2008 .

[13]  Anushree Chatterjee,et al.  Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents? , 2012, Antiviral therapy.

[14]  C. Rice,et al.  Understanding the hepatitis C virus life cycle paves the way for highly effective therapies , 2013, Nature Medicine.

[15]  Darius Moradpour,et al.  Replication of hepatitis C virus , 2007, Nature Reviews Microbiology.

[16]  Alan S. Perelson,et al.  Quantifying the Diversification of Hepatitis C Virus (HCV) during Primary Infection: Estimates of the In Vivo Mutation Rate , 2012, PLoS pathogens.

[17]  A. Neumann,et al.  Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics. , 2010, Journal of theoretical biology.

[18]  S. Ahn,et al.  Emerging Therapies for Hepatitis C , 2014, Gut and liver.

[19]  Ji Hoon Park,et al.  The specific infectivity of hepatitis C virus changes through its life cycle. , 2012, Virology.

[20]  Alan S. Perelson,et al.  Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy , 1998 .

[21]  Alan S. Perelson,et al.  Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon , 2009, Journal of Virology.

[22]  Harel Dahari,et al.  A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease. , 2009, Gastroenterology.

[23]  W. Greene,et al.  Evasion of Superinfection Exclusion and Elimination of Primary Viral RNA by an Adapted Strain of Hepatitis C Virus , 2013, Journal of Virology.